SCHEMBL5482839

SCHEMBL5482839

CO[C]1CCCC(OC)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 0.32
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477824 0.86
SCHEMBL28294894 0.73
SCHEMBL3438344 0.73
SCHEMBL7403559 0.71
SCHEMBL28245854 0.70 PSEN1 (0.45) ADRA1A
SCHEMBL5476461 0.70
SCHEMBL21961599 0.70
SCHEMBL12348668 0.67 IDO1 (0.45) ADRA1A
SCHEMBL28286327 0.67
SCHEMBL2951376 0.67 PDE4A (0.42) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104662027-B Multicomponent mixture of magnesium alkoxide, magnesium halide and alcohol, method for the production thereof and use thereof in a method for producing a catalyst for olefin polymerization 印度石油有限公司 2017-07-18 CN claimed
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids BASF AKTIENGESELLSCHAFT (DE) 2007-11-01 US disclosed
CN-101006062-A Imidazolium-methyl sulfites for use as starting compounds for producing ionic liquids BASF AG (DE) 2007-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids CBR3, SCO2, PRMT5 ADRA1A 4417/4885THRB 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.